期刊文献+

珠海地区妇幼保健院大肠埃希菌产ESBLs的基因型研究 被引量:2

Genotypes Research for E.coli Producing ESBLs in Zhuhai MCH
在线阅读 下载PDF
导出
摘要 目的 了解珠海地区妇幼保健院产超广谱β-内酰胺酶(ESBLs)大肠埃希菌基因特点.方法 收集珠海地区两家妇幼保健院临床分离的316株大肠埃希菌,用法国生物梅里埃公司VITEK-32全自动微生物分析仪检测其表型,再用双纸片法确定,所有产酶菌株用PCR的方法扩增其TEM,CTX M和SHV基因.结果 316株大肠埃希菌检出138株产超广谱β-内酰胺酶(ESBLs),占43.7%(138/316);138株产ESBLs大肠埃希菌PCR检测的结果为TEM型阳性的有72株,CTX M型阳性的有59株,SHV型阳性的有7株,检出率分别为52.2%(72/138),42.8%(59/138)和5.1%(7/138);同时携带TEM型和CTX M型的共23株,占16.6%(23/138).结论 珠海地区妇幼保健院的大肠埃希菌产ESBLs的阳性率高,其基因型别主要以TEM型和CTX-M型为主,同一菌株可携带有两种型别的ESBLs. Objective To learn Zhuhai MCH extended spectrum β lactamases (ESBLs) phenotypes and genes characteristic of Escherichia coli (E.coli).Methods Collected 316 strains of E.coli clinical isolated in zhuhai two maternity and child care.Used VITEK 32 automatic microorganism analyzer which produced by France bioMerieux company to test E.coli phenotype.Then confirmed by dual paper disk method,and PCR method was used for amplification of the TEM,CTX-M and SHV genes of all of the enzyme producing strains.Results 138 strains of ESBLs were found from the 316 strains of E coli,accounted for 43.7 % (138/316).The results of the 138 strains of ESBLs were,72 strains of TEM positive,59 strains of CTX-M positive and 7 strains of SHV positive.Detection rates were 52.2%(72/138),42.8%(59/138) and 5.1%(7/138) respectively.There were 23 strains with TEM positive and CTX M positive simultaneously,accounted for 16.6 % (23/138).Conclusion There was a high positive rate of E.coli of ESBLs in Zhuhai MCH,and their genotypes mainly were TEM and CTX M.It would be possible that one strain carries two kinds of ESBLs.
出处 《现代检验医学杂志》 CAS 2014年第4期40-42,共3页 Journal of Modern Laboratory Medicine
基金 珠海市科工贸信局科研课题(2013281).
关键词 超广谱Β-内酰胺酶 大肠埃希菌 基因 妇幼保健院 extended-spectyumβ-lactamases escherichia coli genotype MCH
  • 相关文献

参考文献9

二级参考文献60

共引文献556

同被引文献23

  • 1Horner C, Fawley W, Morris K, et al. Lscherichia coli bacteraemia: 2 years of prospective regional surveil- lance (2010-2012)[J]. J Antimicrob Chemother, 2014,69(1 ) :91-100.
  • 2Clinical and Laboratry. Performance standards for a- ntimicrobial susceptibility testing; 22th informational supplement I S Wayne : PA, CLSI M 100-S22,2014.
  • 3Dallenne C, Da Costa A, Decre D, et al. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enter- obacteriaeeae[J]. J Antimicrob Cbemother, 2010, 65 (3) :490-495.
  • 4Ghafourian S, Sadeghifard N. Soheili S, et al. Extend- ed spectrum betaqactamases: definition, classification and epidemiology[J]. Curr Issues Mol Biol, 2015 (17):11-22.
  • 5Gakin JC, Gonzcilez Candelas F, Rolain J M, et al. An- tibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world[J]. Front Microbiol, 2013( 4 ) : 9.
  • 6Buynak JD. β-Lactamase inhibitors:a review of the pa- tent literature ( 2010-2013 ) [J]. Expert Opin Ther Pat,2013,23(11) :1469-1481.
  • 7Oteo J, Prez-Vdzquez M, Campos J. Extended-spec- trum [ beta ]-lactamase producing Escherichia coli: changing epidemiology and clinical impact [J]. Curt Opin Infect Dis,2010,23(4):320-326.
  • 8Clinical and Laboratory Standards Institute/National Committee for Clinical Laboratory Standards.Performance standards for anti microbial susceptibiliytesting[S].Wayne:Pennsylvania:NCCLS,M100-S14,2011.
  • 9Park YS,Adams-Haduch JM,Shutt KA,et al.Clinical and microbiklogic characteristics of cephalospo-rin-resistant Escherichia coli at three centers in the United States[J].Antimicrob Agents Chemotther,2012,56(4):1870-1876.
  • 10Vardakas KZ,Tansarli GS,Rafailidis PI,et al.Carbapenems versus altemative antibiotics for the treatment of bacteraemia due to Enterobacteriaceaeproducing extended-spectrum β-lactamases:a systematic review and meta-analysis[J].J Antimicrob Chemother,2012,67(12):2793-2803.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部